TAILIEUCHUNG - Ebook High-Resolution CT of the lung (7/E): Part 2

(BQ) Part 2 book “High-Resolution CT of the lung” has contents: Pneumoconiosis, occupational, and environmental lung disease, hypersensitivity pneumonitis and eosinophilic lung diseases, miscellaneous infiltrative lung diseases, cystic lung diseases, airways diseases, and other contents. | 12 Sarcoidosis I M P O R T A N T T O P I C S PATHOLOGIC FINDINGS  313 RADIOGRAPHIC FINDINGS  313 HIGH-RESOLUTION COMPUTED TOMOGRAPHY FINDINGS 313 ASSOCIATED CONDITIONS AND SARCOID-LIKE REACTIONS 337 DIFFERENTIAL DIAGNOSIS  338 UTILITY OF HIGH-RESOLUTION COMPUTED TOMOGRAPHY 333 Abbreviations Used in This Chapter CWP DLCO EBUS 18 FDG-PET FEV1 FVC 67 GA HAART HLA IFN IL IPF MRI PFT PH PLC SLR TBNA TLC WTC coal worker’s pneumoconiosis carbon monoxide diffusing capacity endobronchial ultrasound 18-fluoro-deoxy-glucose positron emission tomography forced expiratory volume in 1 second forced vital capacity gallium-67-citrate highly active antiretroviral therapy human leukocyte antigen interferon interleukin idiopathic pulmonary fibrosis magnetic resonance imaging pulmonary function test pulmonary hypertension pulmonary lymphangitic carcinomatosis sarcoid-like reaction transbronchial needle aspiration total lung capacity World Trade Center First described in 1877 by Jonathan Hutchinson, sarcoidosis is a multisystem granulomatous disease of unknown cause, characterized by the presence of noncaseating granulomas (1–4). These may resolve spontaneously or progress to fibrosis (5). Sarcoidosis may involve almost any organ, but most morbidity and mortality is the result of pulmonary disease (6). Pulmonary manifestations are present in 90% of patients. Although 30% to 60% of patients with pulmonary sarcoidosis are asymptomatic, 312 with their disease identified incidentally on routine chest radiographs, 20% to 25% of patients will ultimately develop permanent functional impairment (3,4,7,8). Extrathoracic manifestations of sarcoidosis are present in 25% to 50% of cases and are almost always associated with intrathoracic disease. Extrathoracic ­abnormalities commonly include involvement of the liver, spleen, peripheral lymph nodes, and skin, with common cutaneous manifestations, including erythema nodosum and lupus pernio (8). Erythema nodosum occurs in approximately 10%

• Y khoa - Dược
• Environmental lung disease
• Hypersensitivity pneumonitis
• Airways diseases
• Miscellaneous infiltrative lung diseases
• Chronic obstructive pulmonary disease
• The respiratory medicine specialty certificate examination
• Eosinophilic lung disease
• Sleep disorders
• Lung transplantation
• Pulmonary function tests
• Cystic lung diseases
• Pulmonary lymphoproliferative diseases
• Pulmonary hypertension
• BMC Pulmonary Medicine
• Chronic hypersensitivity pneumonitis
• Inhaled environmental antigens
• Lung pathology
• Disease prevalence
• Chronic bronchitis
• Chronic kidney disease
• Glomerular filtration rate
• Pulmonary function
• Meta analysis
• Chronic pulmonary disease management
• Thai Nguyen hospital
• Lung disease
• COPD patients at CMU
• Cardiovascular disease
• Cardiovascular events
• Long acting bronchodilator
• AAT deficiency
• Controlled pilot study
• Increased bacterial loads
• Obstructive pulmonary disease pharmacotherapy
• Chronic lung disease
• Magnetic resonance imaging
• Cerebrovascular disorders
• High sensitivity cardiac troponin T
• Pulmonary embolism
• Disease exacerbation
• Physical therapy modalities
• Exercise therapy
• Pulmonary rehabilitation
• Quality of life
• Health related quality of life
• Co creation
• Participatory research
• Quality of sleep
• COPD patients
• Pulmonary tuberculosis
• Toll like receptor 4
• Single nucleotide polymorphism
• Hemoglobin abnormality
• In hospital mortality
• Population based study
• Coronary heart disease
• Systemic inflammatory
• Physical activity
• Gastroesophageal reflux disease
• Reflux symptoms
• Lung hyperinflation
• Health status
• Respiratory disease
• Disease specific health status
• Knowledge translation
• Knowledge to action
• Chronic systemic inflammatory syndrome
• Acute phase reactants
• C reactive protein
• Serum amyloid A
• Chronic colonization
• Pseudomonas aeruginosa
• Multivariate analysis
• BMC Bioinformatics
• Molecular mechanisms
• Chronic disorders
• Disease gene
• Risk factors
• Lung function
• Biomass exposure
• Pulmonary function test
• Additional screening methods
• Healthy subjects
• Genetic polymorphism
• Nitric oxide synthase
• Machine learning
• Primary care
• FEV1/FVC ratio
• Aspergillus isolation
• Pulmonary aspergillosis
• Lower respiratory tract